Document is current
Any future updates will be listed below
-
Authors
Bairamian, Diane
Sha, Sha
Rolhion, Nathalie
Sokol, Harry
Dorothée, Guillaume
Lemere, Cynthia A.
Krantic, Slavica http://orcid.org/0000-0002-0785-4549
-
Funding
Funding for this research was provided by:
France Alzheimer (MicAD)
Fondation Alzheimer (MicIAD)
National Institutes of Health (RF1 AG060057)
National Aeronautics and Space Administration (80NSSC18K0810)
- License Information
-
More Information
Article History
Received: 10 January 2022
Accepted: 15 February 2022
First Online: 5 March 2022
Declarations
:
: Not applicable.
: Not applicable.
: H.S. received consultancy, or lecture fees, from Carenity, Abbvie, Astellas, Danone, Ferring, Mayoly Spindler, MSD, Novartis, Roche, Tillots, Enterome, Maat, BiomX, Biose, and Takeda and is also a co-founder of Exeliom Bioscience. C.A.L. consults for Acumen Pharmaceuticals, ADvantage Therapeutics, Apellis Pharmaceuticals, Biogen and Cyclotherapeutics. The other authors declare no conflict of interest related to the current work.
